FDA Inspection
APARNA ORGANICS LIMITEDAPARNA ORGANICS LIMITED – FDA Inspection, Mar 15, 2019
Record Details
This FDA Inspection record concerns APARNA ORGANICS LIMITED, with an inspection on March 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Dipesh K. Shah
- Eric L. Dong (Issuing Officer)
- Tenzin Jangchup (FDA Associated Person)
View Company Profile
ID · 4e97b0f0-df03-4367-8141-692c9941c291
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1086615
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of APARNA ORGANICS LIMITED
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 6, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for APARNA ORGANICS LIMITED
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.